ESMO Asia 2019: Industry Sponsored Satellite Symposia

Click on the links below to access the Industry Sponsored Satellite Symposia Invitations.

Friday 22 November 2019

Changing the Course for the Lung Cancer Patient: A New Direction

01-Changing-the-course-for-the-lung-cancer-patient-A-new-direction-ASTRAZENECA-Thumb

Friday, 12:45 - 14:15
View the satellite invitation

PARP Inhibitors as Targeted Therapy for Personalised Medicine

02-PARP-inhibitors-as-targeted-therapy-for-personalised-medicine-ASTRAZENECA-Thumb

Friday, 12:45 - 14:15
View the satellite invitation

From Clinical Trials to Practice: Changing the Trajectory for Metastatic Breast Cancer Patients

04-From-Clinical-Trials-to-Practice-Changing-the-Trajectory-for-Metastatic-Breast-Cancer-Patients-PFIZER-Thumb

Friday, 12:45 - 14:15
View the satellite invitation

Precision Oncology in Asia: A New Dawn or a False Hope?

Precision-Oncology-in-Asia-A-New-Dawn-or-a-False-Hope-ROCHE-thumb

Friday, 12:45 - 14:15
View the satellite invitation

A Quantum Leap in Treatment of NSCLC and HNSCC with IO

MSD Thumb

Friday, 12:45 - 14:15
View the satellite invitation

Saturday 23 November 2019

Evolving the Treatment Practice of Advanced EGFRm NSCLC

07-Evolving-the-treatment-practice-of-advanced-EGFRm-NSCLC-ASTRAZENECA-Thumb

Saturday, 12:45 - 14:15
View the satellite invitation

Treating EGFR+ NSCLC in 2020: New Approaches, Optimal Outcomes

08-Treating-EGFR-NSCLC-in-2020-New-Approaches-Optimal-Outcomes-PFIZER-Thumb

Saturday, 12:45 - 14:15
View the satellite invitation

Advances in Immuno-Oncology: A Pan Tumor Perspective

MSD Thumb

Saturday, 12:45 - 14:15
View the satellite invitation

Evolving Treatment Landscape in ER+ Breast Cancer: Clinical Practice

10-Evolving-Treatment-Landscape-in-ER-Breast-Cancer-Clinical-Practice--NOVARTIS-Thumb

Saturday, 12:45 - 14:15
View the satellite invitation

Recent Advances and Future Possibilities with Immunotherapy in Renal and Urothelial Cancers

31-GU-2.0-Patient-Care-in-2019-and-Beyond-MERCK-PFIZER-Thumb

Saturday, 12:45 - 14:15
View the satellite invitation

Managing HCC Today: How Can We Give Our Patients the Best Chance?

12-Managing-HCC-Today-How-Can-We-Give-Our-Patients-the-Best-Chance-IPSEN-Thumb

Saturday, 12:45 - 14:15
View the satellite invitation

Sunday 24 November 2019

New Paradigm of Treatment Strategy for Intermediate and Advanced HCC

13-New-paradigm-of-treatment-strategy-for-intermediate-and-advanced-HCC-EISAI-Thumb

Sunday 11:00 - 12:30
View the satellite invitation

Cancer Immunotherapy in HCC: The Combination Revolution

14-Cancer-Immunotherapy-in-HCC-The-Combination-Revolution-ROCHE-Thumb

Sunday 11:00 - 12:30
View the satellite invitation

Redefining ALK+ NSCLC Management

Redefining-ALK-NSCLC-Management-TAKEDA-thumb

Sunday 11:00 - 12:30
View the satellite invitation

The New Continuum of Care in mCRC

16-The-New-Continuum-of-Care-in-mCRC-MERCK-Thumb

Sunday 11:00 - 12:30
View the satellite invitation

Please note: The European Society for Medical Oncology (ESMO) does not endorse any of the companies, or their products/services, that have sponsored these links.

View the Complete ESMO Asia 2019 Industry Satellite Symposia Programme